臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"lu y s"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 191-240 of 467 (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-04-21T07:27:41Z	A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women	Tsai M.-S.;Chang S.-H.;Wen-Hung Kuo;Kuo C.-H.;Li S.-Y.;Wang M.-Y.;Chang D.-Y.;Lu Y.-S.;Huang C.-S.;Cheng A.-L.;Lin C.-H.;Chen P.-C.; Tsai M.-S.; Chang S.-H.; WEN-HUNG KUO; Kuo C.-H.; Li S.-Y.; Wang M.-Y.; Chang D.-Y.; Lu Y.-S.; Huang C.-S.; Cheng A.-L.; Lin C.-H.; Chen P.-C.
臺大學術典藏	2021-03-19T06:58:00Z	Angiogenic response of locally advanced breast cancer to neoadjuvant chemotherapy evaluated with parametric histogram from dynamic contrast-enhanced MRI	Yeun-Chung Chang;Huang C.-S.;Liu Y.-J.;Chen J.-H.;Lu Y.-S.;Tseng W.-Y.I.; YEUN-CHUNG CHANG; Huang C.-S.; Liu Y.-J.; Chen J.-H.; Lu Y.-S.; Tseng W.-Y.I.
臺大學術典藏	2021-03-19T06:57:30Z	Evaluation of the treatment response to neoadjuvant chemotherapy in locally advanced breast cancer using combined magnetic resonance vascular maps and apparent diffusion coefficient	Wu L.-A.; Chang R.-F.; Huang C.-S.; Lu Y.-S.; Chen H.-H.; Chen J.-Y.; YEUN-CHUNG CHANG
臺大學術典藏	2021-03-18T05:59:08Z	Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma	Lu Y.-S.; Chou C.-H.; KAI-YUAN TZEN; Gao M.; Cheng A.-L.; Kulp S.K.; Cheng J.C.-H.
臺大學術典藏	2021-03-18T03:23:39Z	The impact of diabetes mellitus on prognosis of early breast cancer in Asia	WEI-WU CHEN; Shao Y.-Y.; Shau W.-Y.; Lin Z.-Z.; Lu Y.-S.; Chen H.-M.; Kuo R.N.C.; Cheng A.-L.; Lai M.-S.
臺大學術典藏	2021-03-18T03:23:39Z	The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines	WEI-WU CHEN; Chang D.-Y.; Huang S.-M.; Lin C.-H.; Hsu C.; Lin M.-H.; Huang C.-S.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏	2021-03-18T03:23:38Z	No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen	WEI-WU CHEN; Chen H.-M.; Lin C.-H.; Huang C.-S.; Cheng A.-L.; Lai M.-S.; Lu Y.-S.
臺大學術典藏	2021-03-18T03:23:37Z	High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country	Lin C.-H.; Shen C.-Y.; Lee J.-H.; Huang C.-S.; Yang C.-H.; Kuo W.-H.; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T.; WEI-WU CHEN; Chen I.-C.; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏	2021-03-18T03:23:37Z	A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis	Wu P.-F.; Lin C.-H.; Kuo C.-H.; WEI-WU CHEN; Yeh D.-C.; Liao H.-W.; Huang S.-M.; Cheng A.-L.; Lu Y.-S.
臺大學術典藏	2021-03-18T03:23:37Z	Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy	Lu Y.-S.; WEI-WU CHEN; Lin C.-H.; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; Chen B.-B.; Chao T.-C.; Huang S.-M.; Huang C.-S.; Shih T.T.-F.; Cheng A.-L.; Taiwan Breast Cancer Consortium
臺大學術典藏	2021-03-18T03:23:36Z	Tailor the adjuvant hormonal manipulation for premenopausal breast cancer patients	WEI-WU CHEN; Lin C.-H.; Lu Y.-S.
臺大學術典藏	2021-03-18T03:23:36Z	TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays	Lin C.-H.; Chen I.-C.; Huang C.-S.; Hu F.-C.; Kuo W.-H.; Kuo K.-T.; Wang C.-C.; Wu P.-F.; Chang D.-Y.; Wang M.-Y.; Chang C.-H.; WEI-WU CHEN; Lu Y.-S.; Cheng A.-L.
臺大學術典藏	2021-03-18T03:23:35Z	A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer	Chen B.-B.; Lu Y.-S.; Lin C.-H.; WEI-WU CHEN; Wu P.-F.; Hsu C.-Y.; Yu C.-W.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏	2021-03-18T03:23:34Z	A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer	WEI-WU CHEN; Yeh D.-C.; Chao T.-Y.; Lin C.-H.; Chow L.W.-C.; Chang D.-Y.; Hsieh Y.-Y.; Huang S.-M.; Cheng A.-L.; Lu Y.-S.; Taiwan Breast Cancer Consortium
臺大學術典藏	2021-03-18T03:23:33Z	Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer	Chen B.-B.; Lu Y.-S.; Yu C.-W.; Lin C.-H.; WEI-WU CHEN; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏	2021-03-18T03:23:31Z	Tumor-infiltrating lymphocyte abundance and programmed death-ligand 1 expression in metaplastic breast carcinoma: implications for distinct immune microenvironments in different metaplastic components	Lien H.-C.; Lee Y.-H.; Chen I.-C.; Lin C.-H.; WEI-WU CHEN; Lu Y.-T.; Lu Y.-S.
臺大學術典藏	2021-03-18T03:23:29Z	Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival	WEI-WU CHEN; Jan I.-S.; Chang D.-Y.; Lin C.-H.; Chen I.-C.; Chen H.-M.; Cheng A.-L.; Lu Y.-S.
臺大學術典藏	2021-03-18T02:03:03Z	Differential expression of glucocorticoid receptor in carcinomas of the human digestive system	Lien H.-C.; Lu Y.-S.; CHIA-TUNG SHUN; Yao Y.-T.; Chang W.-C.; Cheng A.-L.
臺大學術典藏	2021-03-15T06:27:35Z	Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation	Lin P.-H.; Lu Y.-S.; Lin C.-H.; DWANG-YING CHANG; Huang C.-S.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2021-03-15T06:27:35Z	Locoregional therapy improves survival for metastatic breast cancer patients? Benefit remains questionable!	DWANG-YING CHANG; Lin C.-H.; Lu Y.-S.
臺大學術典藏	2021-03-15T06:27:34Z	Distant metastasis in triple-negative breast cancer	Tseng L.M.; Hsu N.C.; Chen S.C.; Lu Y.S.; Lin C.H.; DWANG-YING CHANG; Li H.; Lin Y.C.; Chang H.K.; Chao T.C.; Ouyang F.; Hou M.F.
臺大學術典藏	2021-03-15T06:27:34Z	Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients?	Lin C.-H.; Lu Y.-S.; Huang C.-S.; Kuo K.-T.; Wang C.-C.; You S.-L.; Lin P.-H.; DWANG-YING CHANG; Kuo W.-H.; Chang K.-J.; Cheng A.-L.
臺大學術典藏	2021-03-15T06:27:33Z	Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation	Lin C.-H.; Liu J.M.; Lu Y.-S.; Lan C.; Lee W.-C.; Kuo K.-T.; Wang C.-C.; DWANG-YING CHANG; Huang C.-S.; Cheng A.L.
臺大學術典藏	2021-03-15T06:27:33Z	The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines	Chen W.-W.; DWANG-YING CHANG; Huang S.-M.; Lin C.-H.; Hsu C.; Lin M.-H.; Huang C.-S.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏	2021-03-15T06:27:32Z	High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country	Lin C.-H.; Shen C.-Y.; Lee J.-H.; Huang C.-S.; Yang C.-H.; Kuo W.-H.; DWANG-YING CHANG; Hsiung C.-N.; Kuo K.-T.; Chen W.-W.; Chen I.-C.; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏	2021-03-15T06:27:31Z	A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer	Chen T.W.-W.; Yeh D.-C.; Chao T.-Y.; Lin C.-H.; Chow L.W.-C.; DWANG-YING CHANG; Hsieh Y.-Y.; Huang S.-M.; Cheng A.-L.; Lu Y.-S.; Taiwan Breast Cancer Consortium
臺大學術典藏	2021-03-15T06:27:31Z	TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays	Lin C.-H.; Chen I.-C.; Huang C.-S.; Hu F.-C.; Kuo W.-H.; Kuo K.-T.; Wang C.-C.; Wu P.-F.; DWANG-YING CHANG; Wang M.-Y.; Chang C.-H.; Chen W.-W.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏	2021-03-15T06:27:30Z	A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women	Tsai M.-S.; Chang S.-H.; Kuo W.-H.; Kuo C.-H.; Li S.-Y.; Wang M.-Y.; DWANG-YING CHANG; Lu Y.-S.; Huang C.-S.; Cheng A.-L.; Lin C.-H.; Chen P.-C.
臺大學術典藏	2021-03-15T06:27:30Z	Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival	Chen T.W.-W.; Jan I.-S.; DWANG-YING CHANG; Lin C.-H.; Chen I.-C.; Chen H.-M.; Cheng A.-L.; Lu Y.-S.
臺大學術典藏	2021-03-12T00:50:54Z	Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis	Chen I.-C.; Lin C.-H.; I-SHIOW JAN; Cheng A.-L.; Lu Y.-S.
臺大學術典藏	2021-03-12T00:50:51Z	Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival	Chen T.W.-W.; I-SHIOW JAN; Chang D.-Y.; Lin C.-H.; Chen I.-C.; Chen H.-M.; Cheng A.-L.; Lu Y.-S.
臺大學術典藏	2021-03-10T05:34:20Z	Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer	Yeh K.H.; Lu Y.S.; Hsu C.H.; Lin J.F.; Chao H.J.; Ta-Chen Huang; Chung C.Y.; Chang C.S.; Yang C.H.; Cheng A.L.
臺大學術典藏	2021-03-09T05:18:40Z	Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract	Hsu C.; Ying-Chun Shen; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; Hsu C.-H.; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:38Z	Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma	Ou D.-L.; Ying-Chun Shen; Liang J.-D.; Liou J.-Y.; Yu S.-L.; Fan H.-H.; Wang D.-S.; Lu Y.-S.; Hsu C.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:38Z	Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia	Lin C.-H.; Liau J.-Y.; Lu Y.-S.; Huang C.-S.; Lee W.-C.; Kuo K.-T.; Ying-Chun Shen; Kuo S.-H.; Lan C.; Liu J.M.; Kuo W.-H.; Chang K.-J.; Cheng A.-L.
臺大學術典藏	2021-03-05T06:07:34Z	Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer	Ch'ang H.-J.; Wang C.-C.; Cheng A.-L.; Hsu C.; Lu Y.-S.; MING-CHU CHANG; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T.
臺大學術典藏	2021-02-23T08:26:44Z	Recent advances in the management of primary breast cancers	Lu Y.-S.;Sung-Hsin Kuo;Huang C.-S.; Lu Y.-S.; SUNG-HSIN KUO; Huang C.-S.
臺大學術典藏	2021-02-23T08:26:44Z	Phase II study of combination doxorubicin, interferon-�\, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma	Lu Y.-S.;Hsu C.;Li C.-C.;Sung-Hsin Kuo;Yeh K.-H.;Yang C.-H.;Hsu C.-H.;Wu C.-Y.;Cheng A.-L.; Lu Y.-S.; Hsu C.; Li C.-C.; SUNG-HSIN KUO; Yeh K.-H.; Yang C.-H.; Hsu C.-H.; Wu C.-Y.; Cheng A.-L.
臺大學術典藏	2021-02-23T08:26:42Z	Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer	Yeh K.-H.;Lu Y.-S.;Hsu C.-H.;Lin J.-F.;Hsu C.;Sung-Hsin Kuo;Li Jr. S.;Cheng A.-L.; Yeh K.-H.; Lu Y.-S.; Hsu C.-H.; Lin J.-F.; Hsu C.; SUNG-HSIN KUO; Li Jr. S.; Cheng A.-L.
臺大學術典藏	2021-02-23T08:26:41Z	Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors	Lu Y.-S.;Lien H.-C.;Yeh P.-Y.;Yeh K.-H.;Kuo M.-L.;Sung-Hsin Kuo;Cheng A.-L.; Lu Y.-S.; Lien H.-C.; Yeh P.-Y.; Yeh K.-H.; Kuo M.-L.; SUNG-HSIN KUO; Cheng A.-L.
臺大學術典藏	2021-02-23T08:26:40Z	Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity	Lu Y.-S.;Lien H.-C.;Yeh P.-Y.;Sung-Hsin Kuo;Chang W.-C.;Kuo M.-L.;Cheng A.-L.; Lu Y.-S.; Lien H.-C.; Yeh P.-Y.; SUNG-HSIN KUO; Chang W.-C.; Kuo M.-L.; Cheng A.-L.
臺大學術典藏	2021-02-23T08:26:39Z	Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients	Sung-Hsin Kuo;Lien H.-C.;You S.-L.;Lu Y.-S.;Lin C.-H.;Chen T.-Z.;Huang C.-S.; SUNG-HSIN KUO; Lien H.-C.; You S.-L.; Lu Y.-S.; Lin C.-H.; Chen T.-Z.; Huang C.-S.
臺大學術典藏	2021-02-23T08:26:37Z	The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers	Huang C.-S.;Sung-Hsin Kuo;Lien H.-C.;Yang S.-Y.;You S.-L.;Shen C.-Y.;Lin C.-H.;Lu Y.-S.;Chang K.-J.; Huang C.-S.; SUNG-HSIN KUO; Lien H.-C.; Yang S.-Y.; You S.-L.; Shen C.-Y.; Lin C.-H.; Lu Y.-S.; Chang K.-J.
臺大學術典藏	2021-02-23T08:26:35Z	Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia	Lin C.-H.; Liau J.-Y.; Lu Y.-S.; Huang C.-S.; Lee W.-C.; Kuo K.-T.; Shen Y.-C.; SUNG-HSIN KUO; Lan C.; Liu J.M.; Kuo W.-H.; Chang K.-J.; Cheng A.-L.
臺大學術典藏	2021-02-23T08:26:34Z	Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy	Lin C.-H.;Lien H.-C.;Hu F.-C.;Lu Y.-S.;Sung-Hsin Kuo;Wu L.-C.;You S.-L.;Cheng A.-L.;Chang K.-J.;Huang C.-S.; Lin C.-H.; Lien H.-C.; Hu F.-C.; Lu Y.-S.; SUNG-HSIN KUO; Wu L.-C.; You S.-L.; Cheng A.-L.; Chang K.-J.; Huang C.-S.
臺大學術典藏	2021-02-23T08:26:33Z	Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer	Lu Y.-S.; Chen D.-R.; Tseng L.-M.; Yeh D.-C.; Chen S.-T.; Hsieh C.-M.; Wang H.-C.; Yeh H.-T.; SUNG-HSIN KUO; Huang C.-S.
臺大學術典藏	2021-02-23T08:26:33Z	Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001	Sung-Hsin Kuo;Hsu C.-H.;Chen L.-T.;Lu Y.-S.;Lin C.-H.;Yeh P.-Y.;Jeng H.-J.;Gao M.;Yeh K.-H.;Cheng A.-L.; SUNG-HSIN KUO; Hsu C.-H.; Chen L.-T.; Lu Y.-S.; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2021-02-23T08:26:33Z	Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma	Chiang C.-T.;Yeh P.-Y.;Gao M.;Chen C.-W.;Yeh L.-C.;Feng W.-C.;Sung-Hsin Kuo;Hsu C.-H.;Lu Y.-S.;Cheng A.-L.; Chiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; SUNG-HSIN KUO; Hsu C.-H.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏	2021-02-23T08:26:28Z	CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer	SUNG-HSIN KUO; Yang S.-Y.; Lien H.-C.; Lo C.; Lin C.-H.; Lu Y.-S.; Cheng A.-L.; Chang K.-J.; Huang C.-S.
臺大學術典藏	2021-02-23T08:26:24Z	High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country	Lin C.-H.;Shen C.-Y.;Lee J.-H.;Huang C.-S.;Yang C.-H.;Kuo W.-H.;Chang D.-Y.;Hsiung C.-N.;Kuo K.-T.;Chen W.-W.;Chen I.-C.;Wu P.-F.;Sung-Hsin Kuo;Chen C.-J.;Lu Y.-S.;Cheng A.-L.; Lin C.-H.; Shen C.-Y.; Lee J.-H.; Huang C.-S.; Yang C.-H.; Kuo W.-H.; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T.; Chen W.-W.; Chen I.-C.; Wu P.-F.; SUNG-HSIN KUO; Chen C.-J.; Lu Y.-S.; Cheng A.-L.

Showing items 191-240 of 467 (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 51915027 Online Users : 952 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library